e-learning
resources
Madrid 2019
Sunday, 29.09.2019
Screening tools, prevalence and predictors of obstructive sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence of very severe obstructive sleep apnea syndrome from symptomatic patients.
G. Ernst (Ciudad de Buenos Aires, Argentina), M. Blanco (Ciudad de Buenos Aires, Argentina), S. Schonfeld (Ciudad de Buenos Aires, Argentina), M. Bosio (Ciudad de Buenos Aires, Argentina), A. Salvado (Ciudad de Buenos Aires, Argentina), E. Borsini (Ciudad de Buenos Aires, Argentina)
Source:
International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea
Session:
Screening tools, prevalence and predictors of obstructive sleep apnoea
Session type:
Thematic Poster
Number:
833
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Ernst (Ciudad de Buenos Aires, Argentina), M. Blanco (Ciudad de Buenos Aires, Argentina), S. Schonfeld (Ciudad de Buenos Aires, Argentina), M. Bosio (Ciudad de Buenos Aires, Argentina), A. Salvado (Ciudad de Buenos Aires, Argentina), E. Borsini (Ciudad de Buenos Aires, Argentina). Prevalence of very severe obstructive sleep apnea syndrome from symptomatic patients.. 833
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Investigation of the prevalence of obstructive sleep apnea syndrome in patients with diagnosed subclinicalhypothyroidism
Source: Sleep and Breathing Conference 2021
Year: 2021
Prevalance and characteristics of overlap syndrome in patients with obstructive sleep apnea
Source: Eur Respir J 2002; 20: Suppl. 38, 574s
Year: 2002
Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
Treatment control in risk patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 411s
Year: 2006
Presence of sleep apnea syndrome in the group of severe and very severe COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 198s
Year: 2006
Should patients with obstructive sleep apnea syndrome be screened for hypothyroidism?
Source: Eur Respir J 2005; 26: Suppl. 49, 569s
Year: 2005
Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019
The prevalance of cardiovascular disorders in patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 293s
Year: 2002
Prevalance of daytime hypercapnia in patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 574s
Year: 2002
The symptom prevalence of obstructive sleep apnea syndrome in patients with asthma and COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 198s
Year: 2006
Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
Younger people have more severe obstructive sleep apnea syndrome.
Source: International Congress 2018 – Sleep and breathing control: phenotypes
Year: 2018
Prevalence of glaucoma in obstructive sleep apnea syndrome
Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness
Year: 2010
Enuresis in obstructive sleep apnea syndrome patients
Source: Annual Congress 2012 - Sleep apnoea: clinical topics
Year: 2012
Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007
Prevalence of the metabolic syndrome in untreated Mediterranean patients with the obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
The influence of obesity in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 295s
Year: 2002
Prevalence of thyroid disease in patients with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011
Metabolic syndrome in moderate to severe obstructive sleep apnea?
Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Year: 2020
Assessment of the prevalence of obstructive sleep apnea in patients with undiagnosed chronic cough
Source: Annual Congress 2012 - Sleep disorders in internal medicine
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept